Q&A

Why Has The Demand For Paediatric Products Increased?

Source: Almac Group

Regulatory agencies have issued Guidance to the industry to promote safe medicine for children. Their recommendations for a Paediatric Investigation Plan (Europe) or Pediatric Study Plan (United States) have led to a significant increase in demand for paediatric dosage form development and commercialisation.

access the Q&A!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online

Please tell us more about you so that we can customize our newsletters to your specific interests: